Literature DB >> 16738280

Denosumab in postmenopausal women with low bone mineral density.

Julie Schwartzman, Yusuf Yazici.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738280     DOI: 10.1056/NEJMc060819

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Ibandronate injections in postmenopausal women with osteoporosis.

Authors:  Gim Gee Teng; Nivedita M Patkar; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

2.  Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab.

Authors:  Athanasios D Anastasilakis; Konstantinos A Toulis; Stergios A Polyzos; Chrysostomos D Anastasilakis; Polyzois Makras
Journal:  Ther Clin Risk Manag       Date:  2012-06-19       Impact factor: 2.423

Review 3.  Osteoporosis in the aging male: treatment options.

Authors:  Stephen P Tuck; Harish K Datta
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.